Biotech · Private company
Sermonix Pharmaceuticals Inc.
Track this companyFree. Adds Sermonix Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- FulvestrantPhase 2 · Locally Advanced or Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LasofoxifenePhase 2 · Locally Advanced or Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Lasofoxifene and abemaciclib (VERZENIO (R)).Phase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationPHASE2 · COMPLETED · started Sep 29, 2020ClinicalTrials.gov NCT04432454 · fetched Nov 12, 2026
- Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationPHASE2 · COMPLETED · started Sep 20, 2019ClinicalTrials.gov NCT03781063 · fetched Nov 12, 2026